SUNCIST: A Study of Calmangafodipir in Healthy Japanese and Caucasian Subjects
Status:
Completed
Trial end date:
2017-12-18
Target enrollment:
Participant gender:
Summary
Randomized, double-bline, placebo-controlled, single dose study comparing the
pharmacokinetics (PK) and safety of PP095-01 in Japanese and non-Asian (eg, Caucasian)
subjects.